another phase III failure (BP)

[anonymous]

Another indication bites the dust! bipolar phase 3 trial flops just like agitation in Alzheimer’s ️. Wonder what spin KM will have for us.... https://endpts.com/antipsychotic-fr...n-phiii-trials-this-time-in-bipolar-patients/

 

[anonymous]

I'm out of here. Good luck to all who decide to stay, but I'm done with neuro, done with the metrics, and done with this company that cannot define success

 

[anonymous]

The idiots that run this company should all be fired! It doesn’t matter I guess. The generics will end burying the brand drugs anyway. Me-too drugs like Rexulti are lucky to sell even 1 script.

 

[anonymous]

Keep pushing ambiguity. If these fucktards weren’t wearing it like a fucking badge maybe someone would have jeot an eye on trials. Buh bye rexalti & Maintena. Both are going nowhere.

 

[anonymous]

The only employees held accountable are the account managers. Employees above us can make mistakes and no one has the power to hold them accountable.